Renesola (NYSE:SOL) continues to hike

This story will summarize Renesola. We will check if it is still possible for Renesola to minimize net losses this year. Here I will also expose some primary fundamental factors affecting Renesola's services, and outline how it will impact the outlook for investors this year.
Published over a year ago
View all stories for Emeren | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Raphi Shpitalnik

The company reported the last year's revenue of 139.84 M. Reported Net Loss for the year was (9.89 M) with profit before taxes, overhead, and interest of 34.23 M.
The performance of Emeren Group in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence Emeren's stock prices. When investing in Emeren, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, Emeren Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as Emeren carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.

How important is Emeren's Liquidity

Emeren financial leverage refers to using borrowed capital as a funding source to finance Emeren Group ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Emeren financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Emeren's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Emeren's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Emeren's total debt and its cash.

Emeren Gross Profit

Emeren Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Emeren previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Emeren Gross Profit growth over the last 10 years. Please check Emeren's gross profit and other fundamental indicators for more details.

A Deeper look at Emeren

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Renesola has an asset utilization ratio of 10.39 percent. This denotes that the company is making $0.1 for each dollar of assets. An increasing asset utilization means that Renesola Ltd American is more efficient with each dollar of assets it utilizes for everyday operations.

Our perspective of the new Renesola hike

Total risk alpha is down to 0.51. It may denote a possible volatility pull down. Renesola Ltd American is displaying above-average volatility over the selected time horizon. Investors should scrutinize Renesola Ltd American independently to ensure intended market timing strategies are aligned with expectations about Renesola volatility.

Our Final Take On Renesola

While some other companies within the solar industry are still a little expensive, even after the recent corrections, Renesola may offer a potential longer-term growth to stakeholders. To conclude, as of the 11th of October 2020, our current 30 days advice on the company is Strong Sell. We believe Renesola is overvalued with below average probability of distress for the next two years.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Emeren Group. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com